SlideShare ist ein Scribd-Unternehmen logo
1 von 3
Downloaden Sie, um offline zu lesen
Renal Cell Carcinoma Global Clinical Trials Review, H1, 2014
Renal Cell Carcinoma Global Clinical Trials Review, H1, 2014
Summary
GlobalData's clinical trial report, Renal Cell Carcinoma Global Clinical Trials Review, H1, 2014" provides data on the Renal Cell Carcinoma clinical trial
scenario. This report provides elemental information and data relating to the clinical trials on Renal Cell Carcinoma. It includes an overview of the trial numbers
and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase,
trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Renal Cell Carcinoma. This
report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of
industry experts.
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Scope
- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five
national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)
Reasons to buy
- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
Table Of Contents
table Of Contents 2
list Of Tables 4
list Of Figures 5
introduction 6
renal Cell Carcinoma 6
report Guidance 6
clinical Trials By Region 7
clinical Trials And Average Enrollment By Country 8
top Five Countries Contributing To Clinical Trials In Asia-pacific 10
top Five Countries Contributing To Clinical Trials In Europe 11
top Countries Contributing To Clinical Trials In North America 12
top Five Countries Contributing To Clinical Trials In Middle East And Africa 13
top Five Countries Contributing To Clinical Trials In Central And South America 14
clinical Trials By G7 Countries: Proportion Of Renal Cell Carcinoma To Oncology Clinical Trials 15
clinical Trials By Phase In G7 Countries 16
clinical Trials In G7 Countries By Trial Status 17
clinical Trials By E7 Countries: Proportion Of Renal Cell Carcinoma To Oncology Clinical Trials 18
clinical Trials By Phase In E7 Countries 19
clinical Trials In E7 Countries By Trial Status 20
clinical Trials By Phase 21
in Progress Trials By Phase 22
clinical Trials By Trial Status 23
clinical Trials By End Point Status 24
unaccomplished Trials Of Renal Cell Carcinoma 25
subjects Recruited Over A Period Of Time 34
clinical Trials By Sponsor Type 35
prominent Sponsors 36
top Companies Participating In Renal Cell Carcinoma Therapeutics Clinical Trials 37
prominent Drugs 39
latest Clinical Trials News On Renal Cell Carcinoma 40
apr 16, 2014: Cleveland Biolabs Announces The Successful Completion Of A Phase 1 Study Of Cbl0102 40
apr 07, 2014: Curis And Debiopharm Report Preclinical Data For Debio 0932 At Aacr Annual Meeting 2014 40
dec 05, 2013: Immunicum Reports Positive Phase I/ii-data For The Therapeutic Cancer Vaccine Intuvax In The Treatment Of Kidney Cancer 41
nov 07, 2013: Celldex Therapeutics' Cdx-1127 Well Tolerated And Demonstrates Anti-tumor Activity In Phase 1 Dose-escalation Study 41
sep 26, 2013: Combinability Of Crlx101 And Avastin Established In Clinical Trial In Renal Cell Carcinoma 42
clinical Trial Profiles 44
Renal Cell Carcinoma Global Clinical Trials Review, H1, 2014
clinical Trial Overview Of Top Companies 44
pfizer Inc. 44
clinical Trial Overview Of Pfizer Inc. 44
novartis Ag 50
clinical Trial Overview Of Novartis Ag 50
bayer Ag 54
clinical Trial Overview Of Bayer Ag 54
glaxosmithkline Plc 58
clinical Trial Overview Of Glaxosmithkline Plc 58
f. Hoffmann-la Roche Ltd. 61
clinical Trial Overview Of F. Hoffmann-la Roche Ltd. 61
bristol-myers Squibb Company 64
clinical Trial Overview Of Bristol-myers Squibb Company 64
astrazeneca Plc 66
clinical Trial Overview Of Astrazeneca Plc 66
amgen Inc. 67
clinical Trial Overview Of Amgen Inc. 67
eli Lilly And Company 68
clinical Trial Overview Of Eli Lilly And Company 68
aveo Pharmaceuticals, Inc. 69
clinical Trial Overview Of Aveo Pharmaceuticals, Inc. 69
clinical Trial Overview Of Top Institutes / Government 70
national Cancer Institute 70
clinical Trial Overview Of National Cancer Institute 70
the University Of Texas M. D. Anderson Cancer Center 81
clinical Trial Overview Of The University Of Texas M. D. Anderson Cancer Center 81
memorial Sloan Kettering Cancer Center 83
clinical Trial Overview Of Memorial Sloan Kettering Cancer Center 83
european Organization For Research And Treatment Of Cancer 85
clinical Trial Overview Of European Organization For Research And Treatment Of Cancer 85
ucla's Jonsson Comprehensive Cancer Center 86
clinical Trial Overview Of Ucla's Jonsson Comprehensive Cancer Center 86
roswell Park Cancer Institute 87
clinical Trial Overview Of Roswell Park Cancer Institute 87
case Comprehensive Cancer Center 88
clinical Trial Overview Of Case Comprehensive Cancer Center 88
radboud University 89
clinical Trial Overview Of Radboud University 89
the University Of Chicago 90
clinical Trial Overview Of The University Of Chicago 90
beth Israel Deaconess Medical Center 91
clinical Trial Overview Of Beth Israel Deaconess Medical Center 91
five Key Clinical Profiles 92
appendix 212
abbreviations 212
definitions 212
research Methodology 213
secondary Research 213
about Globaldata 214
contact Us 214
disclaimer 214
source 215
ResearchMoz(http://www.researchmoz.us/) is the one stop online destination to find and buy market research reports & Industry Analysis. We fulfill all your
research needs spanning across industry verticals with our huge collection of market research reports. We provide our services to all sizes of organizations and
across all industry verticals and markets. Our Research Coordinators have in-depth knowledge of reports as well as publishers and will assist you in making an
informed decision by giving you unbiased and deep insights on which reports will satisfy your needs at the best price.
Contact:
M/s Sheela,
90 State Street,
Suite 700,
Albany NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free 866-997-4948
Email: sales@researchmoz.us
Website: http://www.researchmoz.us/
Renal Cell Carcinoma Global Clinical Trials Review, H1, 2014
Renal Cell Carcinoma Global Clinical Trials Review, H1, 2014

Weitere ähnliche Inhalte

Mehr von Ambikabasa

Uveitis global clinical trials review, h1, 2015
Uveitis global clinical trials review, h1, 2015Uveitis global clinical trials review, h1, 2015
Uveitis global clinical trials review, h1, 2015Ambikabasa
 
Cleco corporation power plants and swot analysis, 2015 update
Cleco corporation   power plants and swot analysis, 2015 updateCleco corporation   power plants and swot analysis, 2015 update
Cleco corporation power plants and swot analysis, 2015 updateAmbikabasa
 
Philippines telecoms, mobile and broadband
Philippines   telecoms, mobile and broadbandPhilippines   telecoms, mobile and broadband
Philippines telecoms, mobile and broadbandAmbikabasa
 
Addiction pipeline review, h1 2015
Addiction   pipeline review, h1 2015Addiction   pipeline review, h1 2015
Addiction pipeline review, h1 2015Ambikabasa
 
Arrhythmias pipeline review, h1 2015
Arrhythmias   pipeline review, h1 2015Arrhythmias   pipeline review, h1 2015
Arrhythmias pipeline review, h1 2015Ambikabasa
 
Ocular pain pipeline review, h1 2015
Ocular pain   pipeline review, h1 2015Ocular pain   pipeline review, h1 2015
Ocular pain pipeline review, h1 2015Ambikabasa
 
Paroxysmal nocturnal hemoglobinuria pipeline review, h1 2015
Paroxysmal nocturnal hemoglobinuria   pipeline review, h1 2015Paroxysmal nocturnal hemoglobinuria   pipeline review, h1 2015
Paroxysmal nocturnal hemoglobinuria pipeline review, h1 2015Ambikabasa
 
Rhabdomyosarcoma pipeline review, h1 2015
Rhabdomyosarcoma   pipeline review, h1 2015Rhabdomyosarcoma   pipeline review, h1 2015
Rhabdomyosarcoma pipeline review, h1 2015Ambikabasa
 
Raynauds disease pipeline review, h1 2015
Raynauds disease   pipeline review, h1 2015Raynauds disease   pipeline review, h1 2015
Raynauds disease pipeline review, h1 2015Ambikabasa
 
Travelers diarrhea pipeline review, h1 2015
Travelers diarrhea   pipeline review, h1 2015Travelers diarrhea   pipeline review, h1 2015
Travelers diarrhea pipeline review, h1 2015Ambikabasa
 
Herpes zoster (shingles) pipeline review, h1 2015
Herpes zoster (shingles)   pipeline review, h1 2015Herpes zoster (shingles)   pipeline review, h1 2015
Herpes zoster (shingles) pipeline review, h1 2015Ambikabasa
 
Emphysema pipeline review, h1 2015
Emphysema   pipeline review, h1 2015Emphysema   pipeline review, h1 2015
Emphysema pipeline review, h1 2015Ambikabasa
 
Cerebral infarction (brain infarction) pipeline review, h1 2015
Cerebral infarction (brain infarction)   pipeline review, h1 2015Cerebral infarction (brain infarction)   pipeline review, h1 2015
Cerebral infarction (brain infarction) pipeline review, h1 2015Ambikabasa
 
Seborrhea pipeline review, h1 2015
Seborrhea   pipeline review, h1 2015Seborrhea   pipeline review, h1 2015
Seborrhea pipeline review, h1 2015Ambikabasa
 
Respiratory depression pipeline review, h1 2015
Respiratory depression   pipeline review, h1 2015Respiratory depression   pipeline review, h1 2015
Respiratory depression pipeline review, h1 2015Ambikabasa
 
H1 n1 infection pipeline review, h1 2015
H1 n1 infection   pipeline review, h1 2015H1 n1 infection   pipeline review, h1 2015
H1 n1 infection pipeline review, h1 2015Ambikabasa
 
Nicotine addiction pipeline review, h1 2015
Nicotine addiction   pipeline review, h1 2015Nicotine addiction   pipeline review, h1 2015
Nicotine addiction pipeline review, h1 2015Ambikabasa
 
Food allergy pipeline review, h1 2015
Food allergy   pipeline review, h1 2015Food allergy   pipeline review, h1 2015
Food allergy pipeline review, h1 2015Ambikabasa
 
Uveal melanoma pipeline review, h1 2015
Uveal melanoma   pipeline review, h1 2015Uveal melanoma   pipeline review, h1 2015
Uveal melanoma pipeline review, h1 2015Ambikabasa
 
Tillotts pharma ag product pipeline review - 2015
Tillotts pharma ag   product pipeline review - 2015Tillotts pharma ag   product pipeline review - 2015
Tillotts pharma ag product pipeline review - 2015Ambikabasa
 

Mehr von Ambikabasa (20)

Uveitis global clinical trials review, h1, 2015
Uveitis global clinical trials review, h1, 2015Uveitis global clinical trials review, h1, 2015
Uveitis global clinical trials review, h1, 2015
 
Cleco corporation power plants and swot analysis, 2015 update
Cleco corporation   power plants and swot analysis, 2015 updateCleco corporation   power plants and swot analysis, 2015 update
Cleco corporation power plants and swot analysis, 2015 update
 
Philippines telecoms, mobile and broadband
Philippines   telecoms, mobile and broadbandPhilippines   telecoms, mobile and broadband
Philippines telecoms, mobile and broadband
 
Addiction pipeline review, h1 2015
Addiction   pipeline review, h1 2015Addiction   pipeline review, h1 2015
Addiction pipeline review, h1 2015
 
Arrhythmias pipeline review, h1 2015
Arrhythmias   pipeline review, h1 2015Arrhythmias   pipeline review, h1 2015
Arrhythmias pipeline review, h1 2015
 
Ocular pain pipeline review, h1 2015
Ocular pain   pipeline review, h1 2015Ocular pain   pipeline review, h1 2015
Ocular pain pipeline review, h1 2015
 
Paroxysmal nocturnal hemoglobinuria pipeline review, h1 2015
Paroxysmal nocturnal hemoglobinuria   pipeline review, h1 2015Paroxysmal nocturnal hemoglobinuria   pipeline review, h1 2015
Paroxysmal nocturnal hemoglobinuria pipeline review, h1 2015
 
Rhabdomyosarcoma pipeline review, h1 2015
Rhabdomyosarcoma   pipeline review, h1 2015Rhabdomyosarcoma   pipeline review, h1 2015
Rhabdomyosarcoma pipeline review, h1 2015
 
Raynauds disease pipeline review, h1 2015
Raynauds disease   pipeline review, h1 2015Raynauds disease   pipeline review, h1 2015
Raynauds disease pipeline review, h1 2015
 
Travelers diarrhea pipeline review, h1 2015
Travelers diarrhea   pipeline review, h1 2015Travelers diarrhea   pipeline review, h1 2015
Travelers diarrhea pipeline review, h1 2015
 
Herpes zoster (shingles) pipeline review, h1 2015
Herpes zoster (shingles)   pipeline review, h1 2015Herpes zoster (shingles)   pipeline review, h1 2015
Herpes zoster (shingles) pipeline review, h1 2015
 
Emphysema pipeline review, h1 2015
Emphysema   pipeline review, h1 2015Emphysema   pipeline review, h1 2015
Emphysema pipeline review, h1 2015
 
Cerebral infarction (brain infarction) pipeline review, h1 2015
Cerebral infarction (brain infarction)   pipeline review, h1 2015Cerebral infarction (brain infarction)   pipeline review, h1 2015
Cerebral infarction (brain infarction) pipeline review, h1 2015
 
Seborrhea pipeline review, h1 2015
Seborrhea   pipeline review, h1 2015Seborrhea   pipeline review, h1 2015
Seborrhea pipeline review, h1 2015
 
Respiratory depression pipeline review, h1 2015
Respiratory depression   pipeline review, h1 2015Respiratory depression   pipeline review, h1 2015
Respiratory depression pipeline review, h1 2015
 
H1 n1 infection pipeline review, h1 2015
H1 n1 infection   pipeline review, h1 2015H1 n1 infection   pipeline review, h1 2015
H1 n1 infection pipeline review, h1 2015
 
Nicotine addiction pipeline review, h1 2015
Nicotine addiction   pipeline review, h1 2015Nicotine addiction   pipeline review, h1 2015
Nicotine addiction pipeline review, h1 2015
 
Food allergy pipeline review, h1 2015
Food allergy   pipeline review, h1 2015Food allergy   pipeline review, h1 2015
Food allergy pipeline review, h1 2015
 
Uveal melanoma pipeline review, h1 2015
Uveal melanoma   pipeline review, h1 2015Uveal melanoma   pipeline review, h1 2015
Uveal melanoma pipeline review, h1 2015
 
Tillotts pharma ag product pipeline review - 2015
Tillotts pharma ag   product pipeline review - 2015Tillotts pharma ag   product pipeline review - 2015
Tillotts pharma ag product pipeline review - 2015
 

KĂĽrzlich hochgeladen

8447779800, Low rate Call girls in Shivaji Enclave Delhi NCR
8447779800, Low rate Call girls in Shivaji Enclave Delhi NCR8447779800, Low rate Call girls in Shivaji Enclave Delhi NCR
8447779800, Low rate Call girls in Shivaji Enclave Delhi NCRashishs7044
 
Ms Motilal Padampat Sugar Mills vs. State of Uttar Pradesh & Ors. - A Milesto...
Ms Motilal Padampat Sugar Mills vs. State of Uttar Pradesh & Ors. - A Milesto...Ms Motilal Padampat Sugar Mills vs. State of Uttar Pradesh & Ors. - A Milesto...
Ms Motilal Padampat Sugar Mills vs. State of Uttar Pradesh & Ors. - A Milesto...ShrutiBose4
 
International Business Environments and Operations 16th Global Edition test b...
International Business Environments and Operations 16th Global Edition test b...International Business Environments and Operations 16th Global Edition test b...
International Business Environments and Operations 16th Global Edition test b...ssuserf63bd7
 
Kenya Coconut Production Presentation by Dr. Lalith Perera
Kenya Coconut Production Presentation by Dr. Lalith PereraKenya Coconut Production Presentation by Dr. Lalith Perera
Kenya Coconut Production Presentation by Dr. Lalith Pereraictsugar
 
Global Scenario On Sustainable and Resilient Coconut Industry by Dr. Jelfina...
Global Scenario On Sustainable  and Resilient Coconut Industry by Dr. Jelfina...Global Scenario On Sustainable  and Resilient Coconut Industry by Dr. Jelfina...
Global Scenario On Sustainable and Resilient Coconut Industry by Dr. Jelfina...ictsugar
 
Buy gmail accounts.pdf Buy Old Gmail Accounts
Buy gmail accounts.pdf Buy Old Gmail AccountsBuy gmail accounts.pdf Buy Old Gmail Accounts
Buy gmail accounts.pdf Buy Old Gmail AccountsBuy Verified Accounts
 
Cybersecurity Awareness Training Presentation v2024.03
Cybersecurity Awareness Training Presentation v2024.03Cybersecurity Awareness Training Presentation v2024.03
Cybersecurity Awareness Training Presentation v2024.03DallasHaselhorst
 
Islamabad Escorts | Call 03070433345 | Escort Service in Islamabad
Islamabad Escorts | Call 03070433345 | Escort Service in IslamabadIslamabad Escorts | Call 03070433345 | Escort Service in Islamabad
Islamabad Escorts | Call 03070433345 | Escort Service in IslamabadAyesha Khan
 
Youth Involvement in an Innovative Coconut Value Chain by Mwalimu Menza
Youth Involvement in an Innovative Coconut Value Chain by Mwalimu MenzaYouth Involvement in an Innovative Coconut Value Chain by Mwalimu Menza
Youth Involvement in an Innovative Coconut Value Chain by Mwalimu Menzaictsugar
 
Call Us 📲8800102216📞 Call Girls In DLF City Gurgaon
Call Us 📲8800102216📞 Call Girls In DLF City GurgaonCall Us 📲8800102216📞 Call Girls In DLF City Gurgaon
Call Us 📲8800102216📞 Call Girls In DLF City Gurgaoncallgirls2057
 
IoT Insurance Observatory: summary 2024
IoT Insurance Observatory:  summary 2024IoT Insurance Observatory:  summary 2024
IoT Insurance Observatory: summary 2024Matteo Carbone
 
Future Of Sample Report 2024 | Redacted Version
Future Of Sample Report 2024 | Redacted VersionFuture Of Sample Report 2024 | Redacted Version
Future Of Sample Report 2024 | Redacted VersionMintel Group
 
APRIL2024_UKRAINE_xml_0000000000000 .pdf
APRIL2024_UKRAINE_xml_0000000000000 .pdfAPRIL2024_UKRAINE_xml_0000000000000 .pdf
APRIL2024_UKRAINE_xml_0000000000000 .pdfRbc Rbcua
 
PSCC - Capability Statement Presentation
PSCC - Capability Statement PresentationPSCC - Capability Statement Presentation
PSCC - Capability Statement PresentationAnamaria Contreras
 
8447779800, Low rate Call girls in New Ashok Nagar Delhi NCR
8447779800, Low rate Call girls in New Ashok Nagar Delhi NCR8447779800, Low rate Call girls in New Ashok Nagar Delhi NCR
8447779800, Low rate Call girls in New Ashok Nagar Delhi NCRashishs7044
 
Innovation Conference 5th March 2024.pdf
Innovation Conference 5th March 2024.pdfInnovation Conference 5th March 2024.pdf
Innovation Conference 5th March 2024.pdfrichard876048
 
8447779800, Low rate Call girls in Rohini Delhi NCR
8447779800, Low rate Call girls in Rohini Delhi NCR8447779800, Low rate Call girls in Rohini Delhi NCR
8447779800, Low rate Call girls in Rohini Delhi NCRashishs7044
 
Memorándum de Entendimiento (MoU) entre Codelco y SQM
Memorándum de Entendimiento (MoU) entre Codelco y SQMMemorándum de Entendimiento (MoU) entre Codelco y SQM
Memorándum de Entendimiento (MoU) entre Codelco y SQMVoces Mineras
 
Annual General Meeting Presentation Slides
Annual General Meeting Presentation SlidesAnnual General Meeting Presentation Slides
Annual General Meeting Presentation SlidesKeppelCorporation
 

KĂĽrzlich hochgeladen (20)

8447779800, Low rate Call girls in Shivaji Enclave Delhi NCR
8447779800, Low rate Call girls in Shivaji Enclave Delhi NCR8447779800, Low rate Call girls in Shivaji Enclave Delhi NCR
8447779800, Low rate Call girls in Shivaji Enclave Delhi NCR
 
Ms Motilal Padampat Sugar Mills vs. State of Uttar Pradesh & Ors. - A Milesto...
Ms Motilal Padampat Sugar Mills vs. State of Uttar Pradesh & Ors. - A Milesto...Ms Motilal Padampat Sugar Mills vs. State of Uttar Pradesh & Ors. - A Milesto...
Ms Motilal Padampat Sugar Mills vs. State of Uttar Pradesh & Ors. - A Milesto...
 
International Business Environments and Operations 16th Global Edition test b...
International Business Environments and Operations 16th Global Edition test b...International Business Environments and Operations 16th Global Edition test b...
International Business Environments and Operations 16th Global Edition test b...
 
Kenya Coconut Production Presentation by Dr. Lalith Perera
Kenya Coconut Production Presentation by Dr. Lalith PereraKenya Coconut Production Presentation by Dr. Lalith Perera
Kenya Coconut Production Presentation by Dr. Lalith Perera
 
Global Scenario On Sustainable and Resilient Coconut Industry by Dr. Jelfina...
Global Scenario On Sustainable  and Resilient Coconut Industry by Dr. Jelfina...Global Scenario On Sustainable  and Resilient Coconut Industry by Dr. Jelfina...
Global Scenario On Sustainable and Resilient Coconut Industry by Dr. Jelfina...
 
Buy gmail accounts.pdf Buy Old Gmail Accounts
Buy gmail accounts.pdf Buy Old Gmail AccountsBuy gmail accounts.pdf Buy Old Gmail Accounts
Buy gmail accounts.pdf Buy Old Gmail Accounts
 
Cybersecurity Awareness Training Presentation v2024.03
Cybersecurity Awareness Training Presentation v2024.03Cybersecurity Awareness Training Presentation v2024.03
Cybersecurity Awareness Training Presentation v2024.03
 
Islamabad Escorts | Call 03070433345 | Escort Service in Islamabad
Islamabad Escorts | Call 03070433345 | Escort Service in IslamabadIslamabad Escorts | Call 03070433345 | Escort Service in Islamabad
Islamabad Escorts | Call 03070433345 | Escort Service in Islamabad
 
Youth Involvement in an Innovative Coconut Value Chain by Mwalimu Menza
Youth Involvement in an Innovative Coconut Value Chain by Mwalimu MenzaYouth Involvement in an Innovative Coconut Value Chain by Mwalimu Menza
Youth Involvement in an Innovative Coconut Value Chain by Mwalimu Menza
 
Call Us 📲8800102216📞 Call Girls In DLF City Gurgaon
Call Us 📲8800102216📞 Call Girls In DLF City GurgaonCall Us 📲8800102216📞 Call Girls In DLF City Gurgaon
Call Us 📲8800102216📞 Call Girls In DLF City Gurgaon
 
IoT Insurance Observatory: summary 2024
IoT Insurance Observatory:  summary 2024IoT Insurance Observatory:  summary 2024
IoT Insurance Observatory: summary 2024
 
Future Of Sample Report 2024 | Redacted Version
Future Of Sample Report 2024 | Redacted VersionFuture Of Sample Report 2024 | Redacted Version
Future Of Sample Report 2024 | Redacted Version
 
APRIL2024_UKRAINE_xml_0000000000000 .pdf
APRIL2024_UKRAINE_xml_0000000000000 .pdfAPRIL2024_UKRAINE_xml_0000000000000 .pdf
APRIL2024_UKRAINE_xml_0000000000000 .pdf
 
PSCC - Capability Statement Presentation
PSCC - Capability Statement PresentationPSCC - Capability Statement Presentation
PSCC - Capability Statement Presentation
 
8447779800, Low rate Call girls in New Ashok Nagar Delhi NCR
8447779800, Low rate Call girls in New Ashok Nagar Delhi NCR8447779800, Low rate Call girls in New Ashok Nagar Delhi NCR
8447779800, Low rate Call girls in New Ashok Nagar Delhi NCR
 
Innovation Conference 5th March 2024.pdf
Innovation Conference 5th March 2024.pdfInnovation Conference 5th March 2024.pdf
Innovation Conference 5th March 2024.pdf
 
8447779800, Low rate Call girls in Rohini Delhi NCR
8447779800, Low rate Call girls in Rohini Delhi NCR8447779800, Low rate Call girls in Rohini Delhi NCR
8447779800, Low rate Call girls in Rohini Delhi NCR
 
Memorándum de Entendimiento (MoU) entre Codelco y SQM
Memorándum de Entendimiento (MoU) entre Codelco y SQMMemorándum de Entendimiento (MoU) entre Codelco y SQM
Memorándum de Entendimiento (MoU) entre Codelco y SQM
 
Annual General Meeting Presentation Slides
Annual General Meeting Presentation SlidesAnnual General Meeting Presentation Slides
Annual General Meeting Presentation Slides
 
Japan IT Week 2024 Brochure by 47Billion (English)
Japan IT Week 2024 Brochure by 47Billion (English)Japan IT Week 2024 Brochure by 47Billion (English)
Japan IT Week 2024 Brochure by 47Billion (English)
 

Renal cell carcinoma global clinical trials review, h1, 2014

  • 1. Renal Cell Carcinoma Global Clinical Trials Review, H1, 2014 Renal Cell Carcinoma Global Clinical Trials Review, H1, 2014 Summary GlobalData's clinical trial report, Renal Cell Carcinoma Global Clinical Trials Review, H1, 2014" provides data on the Renal Cell Carcinoma clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Renal Cell Carcinoma. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Renal Cell Carcinoma. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts. Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Scope - Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations - Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type - Listings of discontinued trials (suspended, withdrawn and terminated) Reasons to buy - Understand the dynamics of a particular indication in a condensed manner - Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more - Obtain discontinued trial listing for trials across the globe - Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies Table Of Contents table Of Contents 2 list Of Tables 4 list Of Figures 5 introduction 6 renal Cell Carcinoma 6 report Guidance 6 clinical Trials By Region 7 clinical Trials And Average Enrollment By Country 8 top Five Countries Contributing To Clinical Trials In Asia-pacific 10 top Five Countries Contributing To Clinical Trials In Europe 11 top Countries Contributing To Clinical Trials In North America 12 top Five Countries Contributing To Clinical Trials In Middle East And Africa 13 top Five Countries Contributing To Clinical Trials In Central And South America 14 clinical Trials By G7 Countries: Proportion Of Renal Cell Carcinoma To Oncology Clinical Trials 15 clinical Trials By Phase In G7 Countries 16 clinical Trials In G7 Countries By Trial Status 17 clinical Trials By E7 Countries: Proportion Of Renal Cell Carcinoma To Oncology Clinical Trials 18 clinical Trials By Phase In E7 Countries 19 clinical Trials In E7 Countries By Trial Status 20 clinical Trials By Phase 21 in Progress Trials By Phase 22 clinical Trials By Trial Status 23 clinical Trials By End Point Status 24 unaccomplished Trials Of Renal Cell Carcinoma 25 subjects Recruited Over A Period Of Time 34 clinical Trials By Sponsor Type 35 prominent Sponsors 36 top Companies Participating In Renal Cell Carcinoma Therapeutics Clinical Trials 37 prominent Drugs 39 latest Clinical Trials News On Renal Cell Carcinoma 40 apr 16, 2014: Cleveland Biolabs Announces The Successful Completion Of A Phase 1 Study Of Cbl0102 40 apr 07, 2014: Curis And Debiopharm Report Preclinical Data For Debio 0932 At Aacr Annual Meeting 2014 40 dec 05, 2013: Immunicum Reports Positive Phase I/ii-data For The Therapeutic Cancer Vaccine Intuvax In The Treatment Of Kidney Cancer 41 nov 07, 2013: Celldex Therapeutics' Cdx-1127 Well Tolerated And Demonstrates Anti-tumor Activity In Phase 1 Dose-escalation Study 41 sep 26, 2013: Combinability Of Crlx101 And Avastin Established In Clinical Trial In Renal Cell Carcinoma 42 clinical Trial Profiles 44 Renal Cell Carcinoma Global Clinical Trials Review, H1, 2014
  • 2. clinical Trial Overview Of Top Companies 44 pfizer Inc. 44 clinical Trial Overview Of Pfizer Inc. 44 novartis Ag 50 clinical Trial Overview Of Novartis Ag 50 bayer Ag 54 clinical Trial Overview Of Bayer Ag 54 glaxosmithkline Plc 58 clinical Trial Overview Of Glaxosmithkline Plc 58 f. Hoffmann-la Roche Ltd. 61 clinical Trial Overview Of F. Hoffmann-la Roche Ltd. 61 bristol-myers Squibb Company 64 clinical Trial Overview Of Bristol-myers Squibb Company 64 astrazeneca Plc 66 clinical Trial Overview Of Astrazeneca Plc 66 amgen Inc. 67 clinical Trial Overview Of Amgen Inc. 67 eli Lilly And Company 68 clinical Trial Overview Of Eli Lilly And Company 68 aveo Pharmaceuticals, Inc. 69 clinical Trial Overview Of Aveo Pharmaceuticals, Inc. 69 clinical Trial Overview Of Top Institutes / Government 70 national Cancer Institute 70 clinical Trial Overview Of National Cancer Institute 70 the University Of Texas M. D. Anderson Cancer Center 81 clinical Trial Overview Of The University Of Texas M. D. Anderson Cancer Center 81 memorial Sloan Kettering Cancer Center 83 clinical Trial Overview Of Memorial Sloan Kettering Cancer Center 83 european Organization For Research And Treatment Of Cancer 85 clinical Trial Overview Of European Organization For Research And Treatment Of Cancer 85 ucla's Jonsson Comprehensive Cancer Center 86 clinical Trial Overview Of Ucla's Jonsson Comprehensive Cancer Center 86 roswell Park Cancer Institute 87 clinical Trial Overview Of Roswell Park Cancer Institute 87 case Comprehensive Cancer Center 88 clinical Trial Overview Of Case Comprehensive Cancer Center 88 radboud University 89 clinical Trial Overview Of Radboud University 89 the University Of Chicago 90 clinical Trial Overview Of The University Of Chicago 90 beth Israel Deaconess Medical Center 91 clinical Trial Overview Of Beth Israel Deaconess Medical Center 91 five Key Clinical Profiles 92 appendix 212 abbreviations 212 definitions 212 research Methodology 213 secondary Research 213 about Globaldata 214 contact Us 214 disclaimer 214 source 215 ResearchMoz(http://www.researchmoz.us/) is the one stop online destination to find and buy market research reports & Industry Analysis. We fulfill all your research needs spanning across industry verticals with our huge collection of market research reports. We provide our services to all sizes of organizations and across all industry verticals and markets. Our Research Coordinators have in-depth knowledge of reports as well as publishers and will assist you in making an informed decision by giving you unbiased and deep insights on which reports will satisfy your needs at the best price. Contact: M/s Sheela, 90 State Street, Suite 700, Albany NY - 12207 United States Tel: +1-518-618-1030 USA - Canada Toll Free 866-997-4948 Email: sales@researchmoz.us Website: http://www.researchmoz.us/ Renal Cell Carcinoma Global Clinical Trials Review, H1, 2014
  • 3. Renal Cell Carcinoma Global Clinical Trials Review, H1, 2014